Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma

Annals of Surgical Oncology

Volumn 17, Issue 2, 2010, Pages 371-376

  Russ, Andrew J ^a   Weber, Sharon M ^a   Rettammel, Robert J ^a   Mahvi, David M ^a,b   Rikkers, Layton F ^a   Cho, Clifford S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; COMORBIDITY; CONVALESCENCE; DATA BASE; DISEASE ASSOCIATION; FEMALE; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATIENT DECISION MAKING; PATIENT IDENTIFICATION; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SELECTION BIAS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77149124578     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0759-z     Document Type: Article

References (23)

1. DM Parkin F Bray J Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108 10.3322/canjclin.55.2.74 15761078
2. A Jemal R Siegel E Ward, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin 56 2 106 130 10.3322/canjclin.56.2.106 16514137
3. JP Neoptolemos DD Stocken H Friess, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 1200 1210 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D 15028824 (Pubitemid 38339364)
4. VL Keedy J Berlin 2006 Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer Curr Treat Options Oncol 7 5 381 388 10.1007/s11864-006-0006-9 16904055
5. SF Sener A Fremgen HR Menck, et al. 1999 Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1 1 7 10.1016/S1072- 7515(99)00075-7 1:STN:280:DyaK1MzivVWlsg%3D%3D 10401733 (Pubitemid 29307735)
6. MH Katz H Wang JB Fleming, et al. 2009 Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol 16 4 836 847 10.1245/s10434-008-0295-2 19194760
7. Gastrointestinal Tumor Study Group 1987 Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 12 2006 2010 10.1002/1097-0142(19870615)59: 12<2006::AID-CNCR2820591206>3.0.CO;2-B (Pubitemid 17077780)
8. Y Murakami K Uemura T Sudo, et al. 2008 Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma J Gastrointest Surg 12 3 534 541 10.1007/s11605-007-0407-5 18026816
9. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 3 267 277 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D 17227978 (Pubitemid 46143304)
10. WF Regine KA Winter RA Abrams, et al. 2008 Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 9 1019 1026 10.1001/jama.299.9.1019 1:CAS:528:DC%2BD1cXjtVSltL0%3D 18319412 (Pubitemid 351347058)
11. RC Martin II MF Brennan DP Jaques 2002 Quality of complication reporting in the surgical literature Ann Surg 235 6 803 813 10.1097/00000658-200206000- 00007 12035036 (Pubitemid 34547298)
12. TA Sohn CJ Yeo JL Cameron, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 6 567 579 10.1016/S1091-255X(00)80105-5 1:STN:280: DC%2BD3Mzlt1yqtA%3D%3D 11307091
13. MH Kalser SS Ellenberg 1985 Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 8 899 903 1:STN:280:DyaL2M3ltFSnsQ%3D%3D 4015380
14. G Butturini DD Stocken MN Wente, et al. 2008 Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 1 75 83 10.1001/archsurg.2007.17 18209156 (Pubitemid 351159303)
15. CJ Yeo RA Abrams LB Grochow, et al. 1997 Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 5 621 633 10.1097/00000658-199705000-00018 1:STN:280:DyaK2szjs1Cgug%3D%3D 9193189 (Pubitemid 28079110)
16. FR Spitz JL Abbruzzese JE Lee, et al. 1997 Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 3 928 937 1:STN:280: DyaK2s3htlynsw%3D%3D 9060530
17. JH Klinkenbijl J Jeekel T Sahmoud, et al. 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 6 776 782 10.1097/00000658-199912000-00006 1:STN:280:DC%2BD3c%2FotFKkug%3D%3D 10615932 (Pubitemid 30191812)
18. TA Aloia JE Lee JN Vauthey, et al. 2007 Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg 204 3 347 355 10.1016/j.jamcollsurg.2006.12.011 17324767 (Pubitemid 46283494)
19. NB Merchant J Rymer EAS Koehler, et al. 2009 Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg 208 5 829 841 10.1016/j.jamcollsurg.2008.12.020 19476845
20. MF Brennan RD Moccia D Klimstra 1996 Management of adenocarcinoma of the body and tail of the pancreas Ann Surg 223 5 506 511 10.1097/00000658-199605000- 00006 1:STN:280:DyaK283hvV2qsA%3D%3D 8651741 (Pubitemid 26140343)
21. H Ozaki T Kinoshita T Kosuge, et al. 1996 An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas Cancer 77 11 2240 2245 10.1002/(SICI)1097-0142(19960601)77:11<2240::AID-CNCR9>3.0.CO;2-T 1:STN:280:DyaK283isVyrug%3D%3D 8635090 (Pubitemid 26162415)
22. Y Murakami K Uemura T Sudo, et al. 2009 Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas J Gastrointest Surg 13 1 85 92 10.1007/s11605-008-0650-4 18704593
23. KY Bilimoria DJ Bentrem CY Ko, et al. 2007 Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and hospital volume Cancer 110 6 1227 1234 10.1002/cncr.22916 17654662 (Pubitemid 47435592)